Donna A. Volpe

3.3k total citations · 2 hit papers
62 papers, 2.4k citations indexed

About

Donna A. Volpe is a scholar working on Oncology, Molecular Biology and Pharmacology. According to data from OpenAlex, Donna A. Volpe has authored 62 papers receiving a total of 2.4k indexed citations (citations by other indexed papers that have themselves been cited), including 25 papers in Oncology, 15 papers in Molecular Biology and 14 papers in Pharmacology. Recurrent topics in Donna A. Volpe's work include Drug Transport and Resistance Mechanisms (17 papers), Pharmacogenetics and Drug Metabolism (14 papers) and Pharmacological Effects and Toxicity Studies (10 papers). Donna A. Volpe is often cited by papers focused on Drug Transport and Resistance Mechanisms (17 papers), Pharmacogenetics and Drug Metabolism (14 papers) and Pharmacological Effects and Toxicity Studies (10 papers). Donna A. Volpe collaborates with scholars based in United States, Thailand and Sweden. Donna A. Volpe's co-authors include Charles K. Grieshaber, Robert Parker, Anne‐Marie Tobin, Martin J. Murphy, R. Daniel Mellon, Timothy J. Kropp, Thomas Colatsky, Patrick J. Faustino, S. Leigh Verbois and Aspandiar G. Katki and has published in prestigious journals such as JAMA, PLoS ONE and JNCI Journal of the National Cancer Institute.

In The Last Decade

Donna A. Volpe

60 papers receiving 2.4k citations

Hit Papers

align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

Uniform assessment and ranking of opioid Mu receptor binding constants for selected opioid drugs

2011 315 citations Donna A. Volpe et al. profile →
Effect of Sunscreen Application Under Maximal Use Conditions on Plasma Concentration of Sunscreen Active Ingredients

2019 215 citations Donna A. Volpe, David G. Strauss et al. profile →

Peers

Donna A. Volpe

ONCOL

MB

PHARM

DERMA

PS

Shuji Kitagawa Japan

Saeho Chong United States

Isabelle Fabre France

Ayman El‐Kattan United States

Bruce J. Aungst United States

Hye Suk Lee South Korea

Frank J. Burczynski Canada

P. Uma Devi India

Seon Hwa Lee South Korea

Thomas Szekeres Austria

Shuji Kitagawa Japan

Donna A. Volpe

505 ×0.8

ONCOL

976 ×1.7

MB

305 ×1.1

PHARM

248 ×0.9

DERMA

437 ×1.6

PS

Citations per year, relative to Donna A. Volpe Donna A. Volpe (= 1×) peers Shuji Kitagawa

Countries citing papers authored by Donna A. Volpe

Since Specialization

Citations

This map shows the geographic impact of Donna A. Volpe's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Donna A. Volpe with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Donna A. Volpe more than expected).

Fields of papers citing papers by Donna A. Volpe

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Donna A. Volpe. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Donna A. Volpe. The network helps show where Donna A. Volpe may publish in the future.

Co-authorship network of co-authors of Donna A. Volpe

This figure shows the co-authorship network connecting the top 25 collaborators of Donna A. Volpe. A scholar is included among the top collaborators of Donna A. Volpe based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Donna A. Volpe. Donna A. Volpe is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

1.

Bassan, Arianna, Kevin P. Cross, Xinning Yang, et al.. (2025). Novel (Q)SAR models for prediction of reversible and time-dependent inhibition of cytochrome P450 enzymes. Frontiers in Pharmacology. 15. 1451164–1451164. 1 indexed citations

2.

Volpe, Donna A.. (2024). Knockout Transporter Cell Lines to Assess Substrate Potential Towards Efflux Transporters. The AAPS Journal. 26(4). 79–79.

3.

Sahoo, Dipak Kumar, Marilyn N. Martinez, Albert E. Jergens, et al.. (2023). Canine Intestinal Organoids as a Novel In Vitro Model of Intestinal Drug Permeability: A Proof-of-Concept Study. Cells. 12(9). 1269–1269. 15 indexed citations

4.

Sahoo, Dipak Kumar, Agnes Bourgois‐Mochel, Todd Atherly, et al.. (2022). Canine Intestinal Organoids in a Dual-Chamber Permeable Support System. Journal of Visualized Experiments. 13 indexed citations

5.

Sahoo, Dipak Kumar, Agnes Bourgois‐Mochel, Todd Atherly, et al.. (2022). Canine Intestinal Organoids in a Dual-Chamber Permeable Support System. Journal of Visualized Experiments. 8 indexed citations

6.

Qosa, Hisham, Alexandre J. S. Ribeiro, Neil R. Hartman, & Donna A. Volpe. (2021). Characterization of a commercially available line of iPSC hepatocytes as models of hepatocyte function and toxicity for regulatory purposes. Journal of Pharmacological and Toxicological Methods. 110. 107083–107083. 14 indexed citations

7.

Tran, P., Jiansong Sheng, Aaron Randolph, et al.. (2020). Mechanisms of QT prolongation by buprenorphine cannot be explained by direct hERG channel block. PLoS ONE. 15(11). e0241362–e0241362. 24 indexed citations

8.

Brouwer, Kenneth R., Stephen Ferguson, Yurong Lai, et al.. (2016). The Importance of In Vitro Liver Models: Experts Discuss Whole-Cell Systems, Transporter Function, and the Best Models for Future In Vitro Testing. 2(1). 1–7. 4 indexed citations

9.

Volpe, Donna A.. (2015). Transporter assays as useful in vitro tools in drug discovery and development. Expert Opinion on Drug Discovery. 11(1). 91–103. 31 indexed citations

10.

Volpe, Donna A., et al.. (2013). Use of Different Parameters and Equations for Calculation of IC50 Values in Efflux Assays: Potential Sources of Variability in IC50 Determination. The AAPS Journal. 16(1). 172–180. 56 indexed citations

11.

Li, Jibin, Donna A. Volpe, Ying Wang, et al.. (2011). Use of Transporter Knockdown Caco-2 Cells to Investigate the In Vitro Efflux of Statin Drugs. Drug Metabolism and Disposition. 39(7). 1196–1202. 81 indexed citations

12.

Volpe, Donna A., et al.. (2009). Effect of altered temperature storage on thein vitrocellular uptake of liposome drug products. Journal of Liposome Research. 20(2). 178–182. 1 indexed citations

13.

Asafu-Adjaye, Ebenezer B., Patrick J. Faustino, Mobin A. Tawakkul, et al.. (2007). Validation and application of a stability-indicating HPLC method for the in vitro determination of gastric and intestinal stability of venlafaxine. Journal of Pharmaceutical and Biomedical Analysis. 43(5). 1854–1859. 49 indexed citations

14.

Volpe, Donna A.. (2007). Variability in Caco-2 and MDCK Cell-Based Intestinal Permeability Assays. Journal of Pharmaceutical Sciences. 97(2). 712–725. 179 indexed citations

15.

Volpe, Donna A.. (2004). Permeability classification of representative fluoroquinolones by a cell culture method. PubMed. 6(2). 1–6. 63 indexed citations

16.

Parchment, Ralph E., et al.. (1998). Predicting hematological toxicity (myelosuppression) of cytotoxic drug therapy from in vitro tests. Annals of Oncology. 9(4). 357–364. 54 indexed citations

17.

Volpe, Donna A., et al.. (1996). Myelotoxic effects of the bifunctional alkylating agent bizelesin on human, canine and murine myeloid progenitor cells. Cancer Chemotherapy and Pharmacology. 39(1-2). 143–149. 36 indexed citations

18.

Volpe, Donna A., et al.. (1992). In vitro toxicity of 3′‐azido‐3′‐deoxythymidine, carbovir and 2′, 3′‐didehydro‐2′, 3′‐dideoxythymidine to human and murine haematopoietic progenitor cells. British Journal of Haematology. 80(4). 437–445. 21 indexed citations

19.

Volpe, Donna A., et al.. (1991). Comparative toxicity of fostriecin, hepsulfam and pyrazine diazohydroxide to human and murine hematopoietic progenitor cells in vitro. Investigational New Drugs. 9(2). 149–157. 14 indexed citations

20.

Volpe, Donna A., et al.. (1991). Utility of Human Bone Marrow Obtained Incidental to Orthopedic Surgery for Hematopoietic Clonal Assays. Pathobiology. 59(1). 53–56. 10 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact